Onconetix Inc

Name: Onconetix Inc Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Onconetix Inc

Stock Card

$0.62

$-0.02 (-2.37%)

As on 28-Aug-2026 11:29EDT

Market cap

$3 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

P/B Ratio

0.2

Div. Yield

0 %

Onconetix Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.61 High: 0.64

52 Week Range

Low: 0.61 High: 209.50

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.1 %
ROCE

-- %
Industry P/E

37.31
EV/EBITDA

-0.5
Debt to Equity

0
Book Value

$--
EPS

$-8
Face value

--
Shares outstanding

3,949,107

5 Years Aggregate

CFO

$-25.39 Mln

EBITDA

$-19.45 Mln

Net Profit

$-37.32 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Onconetix	-99.2	-24.2	-47.3	-99.6	--	--	--
BSE Sensex	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2023
Onconetix	-97.1	-82.0
S&P Small-Cap 600	4.0	13.9
BSE Sensex	9.1	18.7

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Onconetix	0.6	2.6	0.7	-10.2	-1,087.3	-69.8	0	0.2
Amneal Pharmaceuticals Inc Class A (AMRX)	17.6	6,238.0	3,117.6	157.4	14.7	--	37.3	188.9
Axsome Therapeutics (AXSM)	201.0	10,883.2	776.6	-191.6	-17.6	-223.4	--	130.9
BridgeBio Pharma (BBIO)	77.2	15,932.7	691.8	-696.2	-89.1	--	--	123.7
Corcept Therapeutics (CORT)	115.2	13,215.0	830.8	54.9	3.2	8.1	271.7	18.7
Elanco Animal Health (ELAN)	24.2	11,971.8	5,020.0	-199.0	1.6	-3	--	1.8
Grifols S.A. - ADR	7.8	5,444.6	7,430.4	452.5	17.6	7	10.4	0.8
Ligand Pharmaceuticals (LGND)	281.0	5,707.4	290.5	197.2	82.5	19.9	29.6	5.9
Liquidia Technologies Inc (LQDA)	68.3	6,142.1	450.9	138.6	39.1	115.6	49	31.5
Twist Bioscience Corp (TWST)	145.8	9,129.6	431.8	-136.7	-30.8	-30.3	--	20.5

Shareholding Pattern

View Details

About Onconetix

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in... vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio. Read more

Interim CEO & Chief Science Officer

Dr. Ralph Schiess Ph.D.
Interim CEO & Chief Science Officer

Dr. Ralph Schiess Ph.D.
Headquarters

Cincinnati, OH
Website

https://www.onconetix.com

FAQs for Onconetix

What is the current share price of Onconetix Inc Today?

The share price of Onconetix Inc is $0.62 (NASDAQ) as of 28-Aug-2026 11:29 EDT. Onconetix Inc has given a return of -99.58% in the last 1 years.

What is the current PB & PE ratio of Onconetix Inc?

Since, TTM earnings of Onconetix Inc is negative, P/E ratio is not available.
The P/B ratio of Onconetix Inc is 0.20 times as on 21-Aug-2026, a 97 discount to its peers’ median range of 7.75 times.

PE & PB ratio at the end of financial year.